Parotto M, Gyöngyösi M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, et al. Post-acute sequelae of COVID-19: Understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739–54.
Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with Post-COVID-19 condition: A systematic review and Meta-analysis. JAMA Intern Med. 2023;183(6):566–80.
Article PubMed PubMed Central Google Scholar
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–07.
Article CAS PubMed Google Scholar
Adjaye-Gbewonyo D, Vahratian A, Perrine CG, Bertolli J. Long COVID in adults: united states, 2022. NCHS Data Brief. 2023;Sep(480):1–8.
Calcaterra V, Zanelli S, Foppiani A, Verduci E, Benatti B, Bollina R et al. Long COVID in children, adults, and vulnerable populations: A comprehensive overview for an integrated approach. Diseases 2024;12(5).
Wang Z, Li Y, Gao Y, Fu Y, Lin J, Lei X, et al. Global, regional, and National burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Respir Res. 2023;24(1):169.
Article CAS PubMed PubMed Central Google Scholar
Assaf S, Stenberg H, Jesenak M, Tarasevych SP, Hanania NA, Diamant Z. Asthma in the era of COVID-19. Respir Med. 2023;218:107373.
Busse WW, Lemanske RF Jr., Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–34.
Article PubMed PubMed Central Google Scholar
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2024. [cited 2024 May]; Available from: www.ginasthma.org.
Hung CT, Hung YC, Suk CW. Prevalence and characteristics in long COVID among adults with asthma in the united States. J Asthma. 2024;61(7):736–44.
Sunata K, Miyata J, Terai H, Matsuyama E, Watase M, Namkoong H, et al. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study. Allergol Int. 2024;73(2):206–13.
Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A et al. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res 2022;9(1):e001056.
National Center for Health Statistics. National Health Interview Survey, 2023 survey description. 2024.
Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma Surveillance - United states, 2006–2018. MMWR Surveill Summ. 2021;70(5):1–32.
Article PubMed PubMed Central Google Scholar
Zhang A, Soogoor N, Crowther T, Vohra S, Jamal A, Srinivasan M, et al. Disparities in adult asthma outcomes among disaggregated data among Asian Americans in the National health interview survey. J Allergy Clin Immunol Glob. 2025;4(3):100458.
Suri R, Macinko J, Inkelas M, Needleman J. The relationship between insurance status and the affordable care act on asthma outcomes among Low-Income US adults. Chest. 2022;161(6):1465–74.
Article PubMed PubMed Central Google Scholar
Laorden D, Domínguez-Ortega J, Carpio C, Barranco P, Villamañán E, Romero D, et al. Long COVID outcomes in an asthmatic cohort and its implications for asthma control. Respir Med. 2023;207:107092.
Wang L, Foer D, Zhang Y, Karlson EW, Bates DW, Zhou L, Post-Acute. COVID-19 respiratory symptoms in patients with asthma: an electronic health Records-Based study. J Allergy Clin Immunol Pract. 2023;11(3):825–e353.
Wolff D, Drewitz KP, Ulrich A, Siegels D, Deckert S, Sprenger AA, et al. Allergic diseases as risk factors for Long-COVID symptoms: systematic review of prospective cohort studies. Clin Exp Allergy. 2023;53(11):1162–76.
Català M, Mercadé-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, spain, and Estonia. Lancet Respir Med. 2024;12(3):225–36.
Hung CT, Hung YC. Telemedicine use among adults with asthma in the united states, 2021–2022. Telemed J E Health. 2024;30(6):1580–87.
Article PubMed PubMed Central Google Scholar
Bossios A, Bacon AM, Eger K, Paróczai D, Schleich F, Hanon S et al. COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma. ERJ Open Res 2023;9(6):00590–2023.
Maier HE, Kowalski-Dobson T, Eckard A, Gherasim C, Manthei D, Meyers A, et al. Reduction in long COVID symptoms and symptom severity in vaccinated compared to unvaccinated adults. Open Forum Infect Dis. 2024;11(2):ofae039.
Article PubMed PubMed Central Google Scholar
Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934–46.
Article CAS PubMed PubMed Central Google Scholar
Bello-Chavolla OY, Fermín-Martínez CA, Ramírez-García D, Vargas-Vázquez A, Fernández-Chirino L, Basile-Alvarez MR, et al. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Health Am. 2024;30:100688.
PubMed PubMed Central Google Scholar
Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in germany: A prospective, multi-centre, population-based cohort study. eClinicalMedicine. 2022;51:101549.
Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139–48.
Comments (0)